Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Wednesday - 1 February 2023

Wednesday, 1 February 2023

Ceisteanna (250)

David Cullinane

Ceist:

250. Deputy David Cullinane asked the Minister for Health if, further to a public statement by his Departmental spokesperson indicating that the HSE completed a comprehensive review of the published HPRA shortages list on 16 January 2023, he will publish this review in full. [4995/23]

Amharc ar fhreagra

Freagraí scríofa

Of the shortages listed on the Health Products Regulatory Authority (HPRA) website on that date, there was no evidence that framework agreements / pricing matters were notified as cause of the shortage. 

Of the 208 notified shortages, the cause were noted as follows:

Manufacturing delay

88

Unexpected Increase in Demand

63

Quality or Regulatory Issue

32

API unavailability

16

Shipping delay

5

Distribution Issue

3

Awaiting Information

1

Grand Total

208

Additionally, across the notified shortages on HPRA website on that date, in 80 cases the relevant company has confirmed “multiple countries affected”.

Barr
Roinn